Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 21,751,284 | 21,751,284 | 0 | $1.31B | $1.09B | 30.04% | -$220.99M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,161,801 | 0 | $131.42M | $207.50M | 5.70% | +$76.08M |
| Revolution Medicines, Inc.(RVMD) | 5,981,212 | 5,981,212 | 0 | $171.54M | $192.77M | 5.30% | +$21.23M |
| 4d Molecular Therapeutics In | 4,007,413 | 3,922,413 | -85,000 | $81.19M | $124.97M | 3.44% | +$43.78M |
| GH Research PLC(GHRS) | 10,400,158 | 10,400,158 | 0 | $60.32M | $110.87M | 3.05% | +$50.54M |
| Janux Therapeutics, Inc.(JANX) | 4,579,818 | 2,919,818 | -1,660,000 | $49.14M | $109.93M | 3.02% | +$60.79M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 4,370,024 | 4,370,024 | 0 | $129.00M | $109.78M | 3.02% | -$19.23M |
| Protagonist Therapeutics Inc | 5,744,848 | 3,755,990 | -1,988,858 | $131.73M | $108.66M | 2.99% | -$23.07M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,428,613 | 2,428,613 | 0 | $122.86M | $105.28M | 2.89% | -$17.58M |
| Olema Pharmaceuticals, Inc.(OLMA) | 9,135,893 | 9,135,893 | 0 | $128.18M | $103.42M | 2.84% | -$24.76M |
| Kura Oncology, Inc.(KURA) | 7,373,228 | 4,786,293 | -2,586,935 | $106.03M | $102.09M | 2.81% | -$3.94M |
| Xoma Corp Del | 3,633,743 | 3,633,743 | 0 | $67.22M | $87.39M | 2.40% | +$20.17M |
| CG Oncology, Inc.(CGON) | 0 | 1,884,191 | +1,884,191 | $0 | $82.72M | 2.27% | +$82.72M |
| Tyra Biosciences, Inc.(TYRA) | 2,739,595 | 4,661,194 | +1,921,599 | $37.94M | $76.44M | 2.10% | +$38.50M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $57.74M | $74.28M | 2.04% | +$16.53M |
| Zymeworks Inc.(ZYME) | 5,870,000 | 5,870,000 | 0 | $60.99M | $61.75M | 1.70% | +$763.1K |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,915,109 | 1,863,809 | -51,300 | $77.85M | $60.01M | 1.65% | -$17.83M |
| Cullinan Therapeutics, Inc.(CGEM) | 3,196,701 | 3,196,701 | 0 | $32.57M | $54.47M | 1.50% | +$21.90M |
| Merus N V | 2,752,420 | 1,172,249 | -1,580,171 | $75.69M | $52.79M | 1.45% | -$22.91M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,729,043 | 1,162,306 | -566,737 | $61.52M | $51.00M | 1.40% | -$10.52M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $31.78M | $50.19M | 1.38% | +$18.41M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $75.44M | $48.67M | 1.34% | -$26.76M |
| 89bio Inc | 4,047,354 | 4,047,354 | 0 | $45.21M | $47.11M | 1.30% | +$1.90M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,875,000 | 1,875,000 | 0 | $40.52M | $44.63M | 1.23% | +$4.11M |
| AC Immune SASHS(ACIU) | 14,571,236 | 14,571,236 | 0 | $72.86M | $43.13M | 1.19% | -$29.73M |
| Third Harmonic Bio Inc | 4,365,933 | 4,365,933 | 0 | $47.89M | $41.21M | 1.13% | -$6.68M |
| Engene Holdings Inc COM | 2,251,037 | 2,251,037 | 0 | $20.78M | $38.16M | 1.05% | +$17.38M |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,521,948 | 1,521,948 | 0 | $17.00M | $35.99M | 0.99% | +$18.99M |
| Structure Therapeutics IncADS | 812,988 | 812,988 | 0 | $33.14M | $34.84M | 0.96% | +$1.71M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,742,409 | 2,742,409 | 0 | $30.80M | $28.90M | 0.79% | -$1.89M |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $22.52M | $28.63M | 0.79% | +$6.11M |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 2,989,474 | 0 | $17.43M | $23.74M | 0.65% | +$6.31M |
| Allakos Inc | 8,552,417 | 16,552,417 | +8,000,000 | $23.35M | $20.86M | 0.57% | -$2.49M |
| Verastem, Inc.(VSTM) | 1,685,219 | 1,685,219 | 0 | $13.72M | $19.89M | 0.55% | +$6.17M |
| Calliditas Therapeutics AbADS | 750,000 | 750,000 | 0 | $19.33M | $16.24M | 0.45% | -$3.09M |
| CytomX Therapeutics, Inc.(CTMX) | 6,595,801 | 6,595,801 | 0 | $10.22M | $14.38M | 0.40% | +$4.16M |
| Elevation Oncology Inc | 2,312,200 | 2,312,200 | 0 | $1.24M | $11.86M | 0.33% | +$10.62M |
| Ovid Therapeutics Inc.(OVID) | 6,851,051 | 3,853,818 | -2,997,233 | $22.06M | $11.75M | 0.32% | -$10.31M |
| Immunic, Inc.(IMUX) | 0 | 8,902,972 | +8,902,972 | $0 | $11.75M | 0.32% | +$11.75M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,000,000 | 2,000,000 | 0 | $10.28M | $10.56M | 0.29% | +$280.0K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 4,326,710 | 4,326,710 | 0 | $7.79M | $8.91M | 0.25% | +$1.12M |
| Verve Therapeutics Inc | 650,000 | 650,000 | 0 | $9.06M | $8.63M | 0.24% | -$429.0K |
| Ikena Oncology Inc | 4,769,164 | 4,769,164 | 0 | $9.40M | $6.77M | 0.19% | -$2.62M |
| Cidara Therapeutics Inc | 6,861,127 | 6,861,127 | 0 | $5.45M | $6.31M | 0.17% | +$864.5K |
| Vigil Neuroscience Inc | 1,813,633 | 1,813,633 | 0 | $6.13M | $6.18M | 0.17% | +$54.4K |
| Delcath Systems, Inc.(DCTH) | 976,149 | 1,202,067 | +225,918 | $4.06M | $5.73M | 0.16% | +$1.67M |
| Unicycive Therapeutics Inc | 2,118,139 | 3,611,601 | +1,493,462 | $1.84M | $4.98M | 0.14% | +$3.15M |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $803.6K | $4.92M | 0.14% | +$4.11M |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 917,826 | +917,826 | $0 | $4.17M | 0.11% | +$4.17M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 24,435,632 | 1,686,924 | -22,748,708 | $37.39M | $4.05M | 0.11% | -$33.34M |
| An2 Therapeutics Inc | 1,563,963 | 1,239,470 | -324,493 | $32.05M | $4.03M | 0.11% | -$28.02M |
| Kronos Bio Inc | 2,905,043 | 2,905,043 | 0 | $3.63M | $3.78M | 0.10% | +$145.3K |
| Pieris Pharmaceuticals Inc | 20,609,863 | 20,609,863 | 0 | $3.75M | $3.78M | 0.10% | +$24.7K |
| Viracta Therapeutics Inc | 3,614,662 | 3,614,662 | 0 | $2.06M | $3.69M | 0.10% | +$1.63M |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $3.07M | $2.48M | 0.07% | -$590.0K |
| Forte Biosciences Inc | 2,982,105 | 2,982,105 | 0 | $2.45M | $2.09M | 0.06% | -$360.8K |
| Molecular Partners AGADS(MOLN) | 443,221 | 443,221 | 0 | $1.76M | $1.72M | 0.05% | -$44.3K |
| Molecular Templates Inc | 532,038 | 522,238 | -9,800 | $1.97M | $1.17M | 0.03% | -$798.7K |
| Nls Pharmaceutics LtdSHS | 5,747,126 | 5,747,126 | 0 | $3.39M | $1.04M | 0.03% | -$2.35M |
| Aslan Pharmaceuticals LtdADS | 1,049,999 | 1,049,999 | 0 | $548.2K | $646.0K | 0.02% | +$97.8K |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,370,947 | 361,406 | -1,009,541 | $2.41M | $643.3K | 0.02% | -$1.77M |
| Rezolute, Inc.(RZLT) | 190,815 | 190,815 | 0 | $189.4K | $486.6K | 0.01% | +$297.2K |
| Axsome Therapeutics, Inc.(AXSM) | 1,981,100 | 0 | -1,981,100 | $157.68M | $0 | — | -$157.68M |
| Centessa Pharmaceuticals PlcADS | 8,774,570 | 0 | -8,774,570 | $69.85M | $0 | — | -$69.85M |
| Immunovant, Inc.(IMVT) | 300,000 | 0 | -300,000 | $12.64M | $0 | — | -$12.64M |
| Iteos Therapeutics Inc | 1,259,476 | 0 | -1,259,476 | $13.79M | $0 | — | -$13.79M |
| Rain Oncology Inc | 3,526,729 | 0 | -3,526,729 | $4.23M | $0 | — | -$4.23M |
| Relay Therapeutics, Inc.(RLAY) | 3,970,045 | 0 | -3,970,045 | $43.71M | $0 | — | -$43.71M |
| SAB Biotherapeutics, Inc.(SABS) | 9,178,282 | 0 | -9,178,282 | $6.31M | $0 | — | -$6.31M |
| Silence Therapeutics plcADS(SLN) | 1,508,416 | 0 | -1,508,416 | $26.20M | $0 | — | -$26.20M |
| Spyre Therapeutics, Inc.(SYRE) | 687,080 | 0 | -687,080 | $14.79M | $0 | — | -$14.79M |
| Sutro Biopharma, Inc.(STRO) | 3,347,946 | 0 | -3,347,946 | $14.36M | $0 | — | -$14.36M |
| Xenon Pharmaceuticals Inc.(XENE) | 890,072 | 0 | -890,072 | $41.00M | $0 | — | -$41.00M |